Bristol Myers: Sotyktu Phase 3 Trials In Psoriatic Arthritis Meet Primary Goals
(RTTNews) - Drug maker Bristol-Myers Squibb Co. (BMY) Monday announced positive topline results from two pivotal Phase 3 trials evaluating Sotyktu (deucravacitinib) in adults with active psoriatic ...
yonkerstimes42 分钟
Arthritis Pain Surge Amid Dropping Temperatures: Reasons and Management Tips
Photo from Pexels.com Frosty mornings, all things pumpkin spice, and hot chocolate—what’s there not to love about the winter ...